Home › Urogenital Cancer › Nebraska › Omaha
Urogenital Cancer clinical trials in Omaha, NE
3 studies for Urogenital Cancer are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi away
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
RecruitingPhase 1/2
- Urology Cancer Center, PC, Omaha
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
RecruitingPhase 1/2
- XCancer Omaha / Urology Cancer Center, Omaha
Urogenital Cancer trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Columbus, OH5 studies
- Nashville, TN5 studies
- Durham, NC4 studies
- Cedar Rapids, IA3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- Ann Arbor, MI3 studies
- Orange, CA3 studies
- Los Angeles, CA3 studies
- Boston, MA3 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Cancer (all types)18 studies
- Colorectal Cancer18 studies
- Multiple Myeloma16 studies
- Ovarian Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Pancreatic Cancer14 studies
- Metastatic Cancer13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.